Nexalin Technology (NXL) Share-based Compensation (2021 - 2026)
Nexalin Technology's quarterly Share-based Compensation came in at $169000.0 in Q1 2026, down 28.09% year-on-year from $235000.0 in Q1 2025, and up 127.9% quarter-over-quarter from -$605734.0 in Q4 2025.
Nexalin Technology has reported Share-based Compensation for 6 years, with the latest figure at $169000.0 in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation fell 28.09% year-over-year to $169000.0; the trailing twelve-month figure through Mar 2026 stood at $881407.0 (down 75.75% YoY), and the FY2025 full-year result was $1.7 million, down 52.65% from the prior year.
- Share-based Compensation for Q1 2026 stood at $169000.0, up from -$605734.0 in the prior quarter.
- The five-year high for Share-based Compensation was $2.4 million in Q4 2023, with the low at -$605734.0 in Q4 2025.
- Average Share-based Compensation over 5 years is $580283.2, with a median of $235000.0 recorded in 2025.
- Peak annual rise in Share-based Compensation reached 45.65% in 2025, while the deepest fall reached 139.04% in 2025.
- Tracing NXL's Share-based Compensation over 5 years: stood at $184291.0 in 2022, then soared by 1209.55% to $2.4 million in 2023, then plunged by 35.7% to $1.6 million in 2024, then tumbled by 139.04% to -$605734.0 in 2025, then soared by 127.9% to $169000.0 in 2026.
- The last three Share-based Compensation figures came in at $169000.0 (Q1 2026), -$605734.0 (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 87.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 94.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 43.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 12.90 Mn |
| 10 | Nexalin Technology | 11.19 Mn | 8.48 Mn | 13,133.00 | 169,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 169,000.00 |
| Mar 31, 2026 | 169,000.00 |
| Dec 31, 2025 | -605,734.00 |
| Dec 31, 2025 | -605,734.00 |
| Sep 30, 2025 | 1.08 Mn |
| Sep 30, 2025 | 1.08 Mn |
| Jun 30, 2025 | 235,351.00 |
| Jun 30, 2025 | 235,351.00 |
| Mar 31, 2025 | 235,000.00 |
| Mar 31, 2025 | 235,000.00 |
| Dec 31, 2024 | 1.55 Mn |
| Dec 31, 2024 | 1.55 Mn |
| Sep 30, 2024 | 1.54 Mn |
| Sep 30, 2024 | 1.54 Mn |
| Jun 30, 2024 | 308,283.00 |
| Jun 30, 2024 | 308,283.00 |
| Mar 31, 2024 | 161,349.00 |
| Mar 31, 2024 | 161,349.00 |
| Dec 31, 2023 | 2.41 Mn |
| Dec 31, 2023 | 2.41 Mn |
| Sep 30, 2022 | 184,291.00 |
| Sep 30, 2022 | 184,291.00 |
| Jun 30, 2022 | 209,100.00 |
| Jun 30, 2022 | 209,100.00 |
| Mar 31, 2022 | 60,000.00 |
| Mar 31, 2022 | 60,000.00 |
| Dec 31, 2021 | 120,002.00 |
| Dec 31, 2021 | 120,002.00 |